Cargando…
Vascular therapy for Duchenne muscular dystrophy (DMD)
Duchenne muscular dystrophy (DMD) is a progressive disease characterized by the wasting of the muscles that eventually lead to difficulty moving and, ultimately, premature death from heart and respiratory complications. DMD deficiency is caused by mutations in the gene encoding dystrophin, which pre...
Autores principales: | Thapa, Sangharsha, Elhadidy, Shaymaa, Asakura, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty Opinions Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979239/ https://www.ncbi.nlm.nih.gov/pubmed/36873982 http://dx.doi.org/10.12703/r/12-3 |
Ejemplares similares
-
Vascular-targeted therapies for Duchenne muscular dystrophy
por: Ennen, James P, et al.
Publicado: (2013) -
Symptomatic therapy of Duchenne Muscular
Dystrophy (DMD)
por: Rüdel, Reinhardt
Publicado: (2012) -
Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
por: REZAEI TAVIRANI, Mostafa, et al.
Publicado: (2017) -
Transition from childhood to adulthood in Duchenne muscular dystrophy (DMD)
por: Rodger, Sunil, et al.
Publicado: (2012) -
Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy
por: Gartz, Melanie, et al.
Publicado: (2020)